Salesforce
CRM
Apple
AAPL
Microsoft
MSFT
Coinbase
COIN
Meta Platforms
META
US Stock MarketDetailed Quotes
LEXX Lexaria Bioscience
- 2.2600
- -0.0800-3.42%
Close Dec 12 16:00 ET
39.44MMarket Cap-4.81P/E (TTM)
2.4200High2.2200Low235.88KVolume2.3300Open2.3400Pre Close536.33KTurnover2.39%Turnover RatioLossP/E (Static)17.45MShares6.850052wk High4.91P/B22.36MFloat Cap1.200052wk Low--Dividend TTM9.89MShs Float12.5000Historical High--Div YieldTTM8.55%Amplitude0.6488Historical Low2.2730Avg Price1Lot Size
About Lexaria Bioscience Company
Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. It operates through the following segments: IP Licensing, B2B Product, Research and Development, and Corporate. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.
Company Profile
SymbolLEXX
Company NameLexaria Bioscience
Listing DateJan 12, 2021
Founded2004
CEOMr. Richard C. Christopher
MarketNASDAQ
Employees7
Fiscal Year Ends08-31
Address740 McCurdy Road,Suite 100
CityKelowna
ProvinceBritish Columbia
CountryCanada
Zip CodeV1X 2P7
Phone1-250-765-6424
Company Executives
- Name
- Position
- Salary
- Richard C. Christopher
- Chief Executive Officer
- 519.32K
- Michael Elliot Shankman
- Chief Financial Officer and Principal Accounting Officer
- --
- John M. Docherty
- President, Principal Executive Officer and Director
- 414.42K
- Christopher Bunka
- Chairman of the Board
- 884.84K
- Nicholas W. Baxter
- Independent Director
- 74.83K
- Albert L. Reese, Jr
- Independent Director
- 74.83K
- William Edward McKechnie
- Independent Director
- 69.83K
- Baljinder Kaur Bhullar
- Independent Director
- --
- Dr. Catherine C. Turkel
- Independent Director
- 74.83K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.